HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Pompholyx of the hands after intravenous immunoglobulin therapy for clinically isolated syndrome: a paediatric case.

Abstract
Pompholyx is a common eruption of small vesicles on the palms, soles, and/or lateral aspects of the fingers. It has a multifactorial etiology, including genetic determinants, allergy to metals, and id reaction; rarely it is a drug-related side effect. We report a paediatric case of pompholyx of the hands related to the intravenous immunoglobulin (IVIG) therapy for Clinically Isolated Syndrome (CIS). A 10-year-old boy, received an IVIG therapy (Venital, Kedrion Spa, Italy) at a dose of 400 mg/kg daily for five days. The fifth day of IVIG infusion, a symmetrical vesicular eruption appeared on the palms of the hands and on lateral aspects of the fingers. The lesions improved with application of topical steroids in few days. The mechanism of induction of pompholyx by IVIG therapy is unknown. A review of the Literature suggests the hypothesis that dyshidrotic eczematous reactions may be related not only to the type of IVIG, to the dose and the rates of infusion, but also to an allergic response to excipients and preservatives contained in the drug, probably elicited by an underlying neurological disease in some cases.
AuthorsV Brazzelli, S Grassi, S Savasta, G Ruffinazzi, A Carugno, V Barbaccia, G L Marseglia, G Borroni
JournalInternational journal of immunopathology and pharmacology (Int J Immunopathol Pharmacol) 2014 Jan-Mar Vol. 27 Issue 1 Pg. 127-30 ISSN: 0394-6320 [Print] England
PMID24674688 (Publication Type: Letter)
Chemical References
  • Adrenal Cortex Hormones
  • Immunoglobulins, Intravenous
Topics
  • Administration, Cutaneous
  • Adrenal Cortex Hormones (administration & dosage, therapeutic use)
  • Child
  • Demyelinating Diseases (drug therapy)
  • Eczema, Dyshidrotic (chemically induced, diagnosis, drug therapy, immunology)
  • Humans
  • Immunoglobulins, Intravenous (administration & dosage, adverse effects, therapeutic use)
  • Male
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: